PALANTIR TECHNOLOGIES INC-A (PTX.DE)

US69608A1088 - Common Stock

77  +3.73 (+5.09%)

Fundamental Rating

5

Taking everything into account, PTX scores 5 out of 10 in our fundamental rating. PTX was compared to 83 industry peers in the Software industry. While PTX has a great health rating, its profitability is only average at the moment. PTX is valued quite expensive, but it does show an excellent growth.



4

1. Profitability

1.1 Basic Checks

PTX had positive earnings in the past year.
In the past year PTX had a positive cash flow from operations.
PTX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PTX reported negative operating cash flow in multiple years.

1.2 Ratios

With a decent Return On Assets value of 8.26%, PTX is doing good in the industry, outperforming 72.60% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.59%, PTX is in the better half of the industry, outperforming 61.64% of the companies in the same industry.
PTX has a Return On Invested Capital (5.33%) which is in line with its industry peers.
Industry RankSector Rank
ROA 8.26%
ROE 10.59%
ROIC 5.33%
ROA(3y)-7.39%
ROA(5y)-20.53%
ROE(3y)-10.41%
ROE(5y)-101.88%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 18.01%, PTX is doing good in the industry, outperforming 75.34% of the companies in the same industry.
The Operating Margin of PTX (13.80%) is better than 67.12% of its industry peers.
PTX has a Gross Margin of 81.10%. This is in the better half of the industry: PTX outperforms 73.97% of its industry peers.
PTX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.8%
PM (TTM) 18.01%
GM 81.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.98%
GM growth 5Y2.23%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PTX is destroying value.
The number of shares outstanding for PTX has been increased compared to 1 year ago.
PTX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 85.62 indicates that PTX is not in any danger for bankruptcy at the moment.
PTX has a better Altman-Z score (85.62) than 100.00% of its industry peers.
PTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 85.62
ROIC/WACC0.46
WACC11.46%

2.3 Liquidity

PTX has a Current Ratio of 5.67. This indicates that PTX is financially healthy and has no problem in meeting its short term obligations.
PTX has a Current ratio of 5.67. This is amongst the best in the industry. PTX outperforms 90.41% of its industry peers.
A Quick Ratio of 5.67 indicates that PTX has no problem at all paying its short term obligations.
PTX has a Quick ratio of 5.67. This is amongst the best in the industry. PTX outperforms 90.41% of its industry peers.
Industry RankSector Rank
Current Ratio 5.67
Quick Ratio 5.67

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.67% over the past year.
PTX shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.52%.
Measured over the past years, PTX shows a very strong growth in Revenue. The Revenue has been growing by 30.17% on average per year.
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)24.52%
Revenue growth 3Y26.75%
Revenue growth 5Y30.17%
Sales Q2Q%29.98%

3.2 Future

PTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.84% yearly.
PTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.75% yearly.
EPS Next Y55.15%
EPS Next 2Y38.73%
EPS Next 3Y32.63%
EPS Next 5Y28.84%
Revenue Next Year26.55%
Revenue Next 2Y25.4%
Revenue Next 3Y23.74%
Revenue Next 5Y22.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 226.47, PTX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of PTX is on the same level as its industry peers.
PTX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 164.82, which means the current valuation is very expensive for PTX.
Based on the Price/Forward Earnings ratio, PTX is valued a bit more expensive than the industry average as 73.97% of the companies are valued more cheaply.
PTX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.69.
Industry RankSector Rank
PE 226.47
Fwd PE 164.82

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PTX is valued a bit more expensive than the industry average as 79.45% of the companies are valued more cheaply.
PTX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PTX is more expensive than 67.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 184.2
EV/EBITDA 433.01

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PTX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PTX's earnings are expected to grow with 32.63% in the coming years.
PEG (NY)4.11
PEG (5Y)N/A
EPS Next 2Y38.73%
EPS Next 3Y32.63%

0

5. Dividend

5.1 Amount

PTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALANTIR TECHNOLOGIES INC-A

FRA:PTX (1/3/2025, 7:00:00 PM)

77

+3.73 (+5.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-03 2025-02-03/amc
Inst Owners44.45%
Inst Owner ChangeN/A
Ins Owners5.18%
Ins Owner ChangeN/A
Market Cap175.33B
Analysts53.08
Price Target39.81 (-48.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.52%
Min EPS beat(2)8.41%
Max EPS beat(2)8.62%
EPS beat(4)4
Avg EPS beat(4)5.28%
Min EPS beat(4)0%
Max EPS beat(4)8.62%
EPS beat(8)7
Avg EPS beat(8)13.75%
EPS beat(12)7
Avg EPS beat(12)-12.82%
EPS beat(16)11
Avg EPS beat(16)3.48%
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)1.15%
Max Revenue beat(2)1.95%
Revenue beat(4)2
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)4
Avg Revenue beat(12)-0.21%
Revenue beat(16)7
Avg Revenue beat(16)0.47%
PT rev (1m)47.88%
PT rev (3m)62.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.8%
EPS NY rev (1m)0%
EPS NY rev (3m)6.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
Industry RankSector Rank
PE 226.47
Fwd PE 164.82
P/S 68.24
P/FCF 184.2
P/OCF 181.53
P/B 40.14
P/tB 40.32
EV/EBITDA 433.01
EPS(TTM)0.34
EY0.44%
EPS(NY)0.47
Fwd EY0.61%
FCF(TTM)0.42
FCFY0.54%
OCF(TTM)0.42
OCFY0.55%
SpS1.13
BVpS1.92
TBVpS1.91
PEG (NY)4.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.26%
ROE 10.59%
ROCE 7.57%
ROIC 5.33%
ROICexc 98.88%
ROICexgc 106.89%
OM 13.8%
PM (TTM) 18.01%
GM 81.1%
FCFM 37.04%
ROA(3y)-7.39%
ROA(5y)-20.53%
ROE(3y)-10.41%
ROE(5y)-101.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.98%
GM growth 5Y2.23%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.2%
Cap/Sales 0.54%
Interest Coverage 250
Cash Conversion 250.11%
Profit Quality 205.7%
Current Ratio 5.67
Quick Ratio 5.67
Altman-Z 85.62
F-Score7
WACC11.46%
ROIC/WACC0.46
Cap/Depr(3y)102.6%
Cap/Depr(5y)100.58%
Cap/Sales(3y)1.2%
Cap/Sales(5y)1.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y55.15%
EPS Next 2Y38.73%
EPS Next 3Y32.63%
EPS Next 5Y28.84%
Revenue 1Y (TTM)24.52%
Revenue growth 3Y26.75%
Revenue growth 5Y30.17%
Sales Q2Q%29.98%
Revenue Next Year26.55%
Revenue Next 2Y25.4%
Revenue Next 3Y23.74%
Revenue Next 5Y22.75%
EBIT growth 1Y904.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.41%
EBIT Next 3Y40.44%
EBIT Next 5Y24.22%
FCF growth 1Y396.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y317.24%
OCF growth 3YN/A
OCF growth 5YN/A